DUBLIN--(BUSINESS WIRE)--The "Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The Global Transfer Membrane Market is Projected to Reach 187.9 Million By 2023 from USD 174.8 Million in 2018, at a CAGR of 1.5%.
Factors such as increasing financial support from public and private funding sources for life science research, high prevalence of target diseases across the globe, and increasing research and development expenditure by pharmaceutical and biotechnology companies, are expected to propel the growth of this market.
However, availability of alternative technologies for protein/nucleic acid quantification and analysis, featuring higher efficiency, end-to-end automation, and high-throughput capabilities such as RT-PCR, is expected to restrain the growth of the transfer membrane market in the forecast period.
The transfer membrane market, by application, is segmented into southern blotting, northern blotting, western blotting, protein sequencing & amino acid analysis, and other applications. The western blotting segment is expected to command the largest share of the transfer membrane market in 2018.
The largest share of this segment can be attributed to rising incidence of autoimmune disease, allergy, and infectious diseases and significant application of western blotting in clinical diagnosis & post-treatment monitoring of these diseases.
On the basis of end user, the transfer membrane market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic and research institutes segment is estimated to witness highest growth during 2018-2023.
Rising financial support from private as well as government bodies for life science research in various nations is expected to increase the demand for consumables such as transfer membranes, which is among the major factors contributing to the growth of this market segment.
- Atto Corporation
- Axiva Sichem Biotech
- Azure Biosystems
- Bio-Rad Laboratories
- Carl Roth
- GE Healthcare
- Merck KGaA
- Pall Corporation (Subsidiary of Danaher Corporation)
- Santa Cruz Biotechnology
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/sqlnz6/179_million?w=4